Hypertriglyceridemia in transgenic mice overexpressing human APO A-II is due to defective catabolism by lipoprotein lipase

被引：0
|
作者：
Kalopissis, AD
Lambert, G
Boisfer, E
Atger, V
Beaucamp, I
Antonucci, M
Laplaud, M
Griglio, S
Chambaz, J
机构：
[1] Inst Cordeliers, INSERM, CJF 9508, Paris, France
[2] Hop Broussais, Biochim Lab, F-75674 Paris, France
[3] Hop Pitie, INSERM, U321, F-75651 Paris, France
来源：
ATHEROSCLEROSIS | 1998年 / 138卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
22
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [1] Overexpression of human apolipoprotein A-II in mice induces hypertriglyceridemia due to defective very low density lipoprotein hydrolysis
    Boisfer, E
    Lambert, G
    Atger, V
    Tran, NQ
    Pastier, D
    Benetollo, C
    Trottier, JF
    Beaucamps, I
    Antonucci, M
    Laplaud, M
    Griglio, S
    Chambaz, J
    Kalopissis, AD
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (17) : 11564 - 11572
  • [2] Protective effect of human apo A-II overexpression on atherogenesis in transgenic mice
    Hennuyer, N
    Tailleux, A
    Caillaud, JM
    Fruchart, JC
    Denefle, P
    Duverger, N
    Fievet, C
    ATHEROSCLEROSIS, 1997, 130 : 132 - 132
  • [3] Antioxidant properties of HDL in transgenic mice overexpressing human apolipoprotein A-II
    Boisfer, E
    Stengel, D
    Pastier, D
    Laplaud, PM
    Dousset, N
    Ninio, E
    Kalopissis, AD
    JOURNAL OF LIPID RESEARCH, 2002, 43 (05) : 732 - 741
  • [4] Hyperglycemia and hypertriglyceridemia in hormone sensitive lipase-overexpressing transgenic mice
    Ebara, T
    Xu, Y
    Kraemer, FB
    Reue, K
    Ginsberg, HN
    Shachter, NS
    DIABETES, 1998, 47 : A32 - A32
  • [5] Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II
    MarzalCasacuberta, A
    BlancoVaca, F
    Ishida, BY
    JulveGil, J
    Shen, JH
    CalvetMarquez, S
    GonzalezSastre, F
    Chan, L
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (12) : 6720 - 6728
  • [6] Effect of human apo A-II overexpression on apo A-I metabolism and HDL structure in transgenic mice
    Kalopissis, AD
    Boisfer, E
    Pastier, D
    Griglio, S
    Laplaud, M
    Quang, NT
    Chambaz, J
    ATHEROSCLEROSIS, 1999, 144 : 167 - 167
  • [7] Cholesterol homeostatic mechanisms in apo A-II expressing transgenic mice
    Kalopissis, AD
    Pastier, D
    Boisfer, E
    Atger, V
    Laplaud, M
    Quang, NT
    Griglio, S
    Chambaz, J
    ATHEROSCLEROSIS, 1999, 144 : 164 - 164
  • [8] Apolipoprotein A-II induces HDL formation by macrophages of control and human apo A-II-transgenic mice
    Rousset, X.
    Fournier, N.
    Fourchaud, L.
    Pastier, D.
    Paul, J. L.
    Chambaz, J.
    Chabert, M.
    Kalopissis, A. D.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 538 - 538
  • [9] MECHANISM OF HYPERTRIGLYCERIDEMIA IN HUMAN APO-CIII TRANSGENIC MICE
    AALTOSETALA, K
    FISHER, EA
    CHEN, XL
    CHAJEKSHAUL, T
    HAYEK, T
    ZECHNER, R
    WALSH, A
    RAMAKRISHNAN, R
    GINSBERG, HN
    BRESLOW, JL
    CIRCULATION, 1992, 86 (04) : 278 - 278
  • [10] Reduction of plasma triglycerides in apolipoprotein C-II transgenic mice overexpressing lipoprotein lipase in muscle
    Pulawa, Leslie K.
    Jensen, Dalan R.
    Coates, Alison
    Eckel, Robert H.
    JOURNAL OF LIPID RESEARCH, 2007, 48 (01) : 145 - 151
12345